Restricted accessResearch articleFirst published online 2017-09
Recommendations of the Fertility Preservation Working Group in Oncological,Hematological and Other Patients Treated With Gonadotoxic Therapies “ONCOFERTILITY” (GROF) of the Polish Society of Oncological Gynecology
DidkowskaJ, WojciechowskaU. Malignant Tumour Morbidity and Mortality in Poland. The National Cancer Registry, Oncology Centre—Maria Skłodowska-Curie Institute. Accessed May11, 2015 from: http://onkologia.org.pl/nowotwory-zlosliwe-ogolem-2
MaltarisT, SeufertR, FischlF, et al.Theeffect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol. 2007; 130:148–55.
9.
LorenAW, PamelaB. Mangu, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice, guideline update. J Clin Oncol., 2013; 31:2500–510.
10.
HourvitzA, GoldschlagDE, DavisOK, et al.Intracytoplasmic sperm injection (ICSI) using cryo-preserved sperm from men with malignant neo-plasm yields high pregnancy rates. Fertil Steril. 2008; 90:557–63.
11.
RomeriusP, StåhlO, MoëllC, et al.Sperm DNA integrity in men treated for childhood cancer. Clin Cancer Res. 2010; 16:3843–50.
12.
SaloniaA, GallinaA, MatloobR, et al.Is sperm banking of interest to patients with nongerm cell urological cancer before potentially fertility damaging treatments?. J Urol. 2009; 182:1101–107.
13.
SchmidtKT, AndersenCY. Recommendations for fertility preservation in patients with lymphomas. J Assist Reprod Genet. 2012; 29:473–7.
14.
ChangHC, ChenSC, ChenJ, et al.Initial 10-year experience of sperm cryopreservation services for cancer patients. J Formos Med Assoc. 2006; 105:1022–6.
15.
YeeS, Fuller-ThomsonE, DwyerC, et al.“Just what the doctor ordered”: factors associated with oncology patients' decision to bank sperm. Can Urol Assoc J. 2012; 6:E174–8.
16.
PingP, ZhuWB, ZhangXZ, et al.Sperm banking for male reproductive preservation: a 6-year retrospective multi-centre study in China. Asian J Androl. 2010; 12:356–62.
17.
Navarro MedinaP, Barroso DeyneE, Castillo SuárezM, et al.An analysis of our experience incryopreservation of semen from cancer patients [in Spanish]. Actas Urol Esp. 2010; 34:101–105.
18.
SönmezerM, TürkçüoğluI, CoşkunU, et al.Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011; 95:2125.e9–11.
19.
AzimAA, Costantini-FerrandoM, OktayK. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008; 26:2630–35.
20.
OktayK, BuyukE, LibertellaN, et al.Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005; 23:4347–53.
21.
LeeS, OktayK. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?. Fertil Steril. 2012; 98:961.e1–964.e1.
22.
OktayK, HourvitzA, SahinG, et al.Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006; 91:3885–90.
23.
AzimAA, Costantini-FerrandoM, LostrittoK, et al.Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab. 2007; 92:2197–200.
24.
JerussJS, WoodruffTK. Preservation of fertility in patients with cancer. N Engl J Med. 2009; 360:902–911.
25.
De VosM, SmitzJ, WoodruffTK. Fertility preservation in women with cancer. Lancet. 2014; 384:1302–310.
26.
BacigalupoA, BallenK, RizzoD, et al.Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009; 15:1628–33.
27.
BoriniA, BianchiV. Cryopreservation of mature and immature oocytes. Clin Obstet Gynecol. 2010; 53:763–74.
28.
HuangJY, ChianRC, GilbertL, et al.Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am J Surg. 2010; 200:177–83.
29.
RudickB, OpperN, PaulsonR, et al.The status of oocyte cryopreservation in the United States. Fertil Steril. 2010; 94:2642–6.
30.
Del MastroL, BoniL, MichelottiA, et al.Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011; 306:269–76.
31.
LoiblS, GerberB. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer. JAMA. 2011; 306:1760, 1761.
MeirowD, LevronJ, Eldar-GevaT, et al.Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005; 353:318–21.
34.
BartonSE, MissmerSA, BerryKF, et al.Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies. Fertil Steril. 2012; 97:381–6.
35.
HalterJ, KoderaY, IspizuaAU, et al.Severeevents in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009; 94:94–101.
36.
OktayK, CilAP, BangH. Efficiency of oocytecryopreservation: a meta-analysis. Fertil Steril. 2006; 86:70–80.
37.
DonnezJ, SquiffletJ, JadoulP, et al.Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril. 2011; 95:1787.e1–4.
38.
KimMK, LeeDR, HanJE, et al.Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation. J Assist Reprod Genet. 2011; 28:1167–70.
39.
IsachenkoV, IsachenkoE, KeckG, et al.First live birth in Germany after re-transplantation of cryopreserved ovarian tissue: original device for initiation of ice formation. Clin Lab. 2012; 58:933–8.
40.
DittrichR, LotzL, KeckG, et al.Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012; 97:387–90.
41.
AndersenCY, SilberSJ, BergholdSH, et al.Long-term duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online. 2012; 25:128–32.
42.
OktayK, TürkçüoğluI, Rodriguez-WallbergKA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: what is the explanation?. Fertil Steril. 2011; 95:804.e7–10.
43.
TitusS, LiF, StobezkiR, et al.Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013; 5:172ra21.
44.
AndersonRA, WallaceWH, BairdDT. Ovarian cryopreservation for fertility preservation: indications and outcomes. Reproduction. 2008; 136:681–9.
45.
JadoulP, DolmansMM, DonnezJ. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?. Hum Reprod Update. 2010; 16:617–30.
AugenJ, SermondadeN, EustacheF. Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations. Basic Clin Androl. 2016; 26:3.
48.
TomlinsonM, MeadowsJ, KohutT, et al.Review and follow-up of patients using regional sperm cryopreservation service: ensuring that resources are targeted to those patients most in need. Andrology. 2015; 3:709–716.
49.
LorenAW, ManguPB, BeckLN, et al.Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice update. J Clin Oncol. 2013; 31:2500–510.
50.
KawanoM, KomuraH, KawaguchiH, et al.Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation. Gynecol Endocrinol. 2016; 3:1–4.
51.
LasicaM, TaylorE, BhattacharayyaP, et al.Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning. Eur J Haematol. 2016; 97:348–52.
52.
GuidaM, CastaldiMA, RosamilioR, et al.Reproductive issues in patients undergoing hematopoietic stem cell transplantation: an update. J Ovarian Res. 2016; 9:72–9.
53.
ChemaitillyW, SklarCA. Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer. 2010; 17:141–59.
54.
YeeS, AbrolK, McDonaldM, et al.Addressing oncofertility needs: views of female cancer patients in fertility preservation. J Psychosoc Oncol. 2012; 30:331–46.
55.
Campfield BonadiesD, MoyerA, MatloffET. What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy. Fam Cancer. 2011; 10:79–85.
56.
GalwayK, BlackA, CantwellM, et al.Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev. 2012; 11:CD007064.